当前位置: 首页 > 期刊 > 《中国现代医生》 > 202022
编号:13820416
同型半胱氨酸在慢性肾脏病心血管疾病发生发展中研究进展(8)
http://www.100md.com 2020年8月5日 《中国现代医生》 202022
     [48] Wrone EM,Zehnder JL,Hornberger JM,et al.An MTHFR variant,homocysteine,and cardiovascular comorbidity in renal disease[J]. Kidney International,2001,60(3):1106-1113.

    [49] Stenvinkel P,Heimburger O,Lindholm B,et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition,inflammation and atherosclerosis (MIA syndrome)[J]. Nephrol Dial Transplant,2000,15(7):953-960.

    [50] Momtazi-Borojeni AA,Jaafaeri MR,Badiee A,et al.Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis[J].BMC Med,2019,17(1):223.

    [51] House AA,Eliasziw M,attran DC,et al. Effect of B-vitamin therapy on progression of diabetic nephropathy:A randomized controlled trial[J].JAMA,2010,303(16):1603-1609.

    [52] Wrone EM,Hornberger JM,Zehnder JL,et al.Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease[J].J Am Soc Nephrol,2004,15(2):420-426.

    [53] Zoungas S,Mcgrath BP,Branley P,et al.Cardiovascular morbidity and mortality in the atherosclerosis and folic acid supplementation trial(ASFAST) in chronic renal failure:A multicenter,randomized,controlled trial[J].J Am Coll Cardiol,2006,47(6):1108-1116.

    (收稿日期:2020-01-13), 百拇医药(李忆 张艳宁)
上一页1 2 3 4 5 6 7 8